JMCP August 2025 Issue

JMCP 30th Anniversary

In this Issue

Research

Identifying and characterizing commercially insured patients with HFpEF with high vs low health care resource utilization
J. Earl, L. A. Hart, and R. N. Hansen

Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
H. Alshannaq, J. Matuoka, R. F. Pollock, W. Ahmed, P. Lynch, and G. J. Norman

Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gaps
C. P. Renfro, J. Fann, J. DeClercq, R. D. Baggett, P. Nichols, M. Kozlicki, L. Choi, and A. D. Zuckerman

Real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals: An analysis using the Premier Healthcare Database
C. R. Tan, E. Chinaeke, N. Kim, D. Lin, L. Hester, J. Fowler, D. Gifkins, S. Walker, A. Z. Fu, and B. Wu

Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare data
F. H. Frech, G. Li, T. R. Juday, Y. Ding, S. Mattke, A. S. Khachaturian, A. S. Rosenberg, C. Ndiba-Markey, A. Rava, R. Batrla, S. De Santi, and H. Hampel

Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout
J. G. Rizk, D. M. Qato, C. O. Bingham, and S. dosReis

Research Brief
Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns
J. F. Merola, S. Welby, H. Roque, J. Song, O. Pilipczuk, C. Lu, and J. A. Walsh

Viewpoint
Will the emerging private-label market access channel help or hinder biosimilar market access?
S. R. Mehr

Caring for communities: A 4-year pharmacy partnership focused on diabetes and cardiovascular health
W. Nuffer, A. Thompson, K. Stenhoff, and M. Bjork

Perspectives
The effectiveness and value of sonpiretigene isteparvovec for the treatment of advanced retinitis pigmentosa
B. Herce-Hagiwara, A. McKenna, A. N. Makam, M. Richardson, W. Lee, M. Phillips, D. M. Rind, and F. Agboola

Supplements

Payer best practices in food allergy management
T. Richardson, S. Wescott, R. Gupta, R. Haumschild, M. Kobernick, J. Albright, M. Abdo, and J. Bioc

Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed care
B. Flavin, J. Bioc, J. Evans, R. Lich, T. O’Shea, and H. Pourarsalan

COMPLETE ISSUE 

JMCP, August 2025, Volume 31, Number 8

Sponsor the JMCP 30th Anniversary! 

Align your brand with 30 years of JMCP and advancing the conversation in managed care pharmacy. New advertising packages available through 2025 include: 

  • Full and half-page print ads with special anniversary branding 
  • Page takeover ads on AMCP.org and JMCP.org 
  • Recognition in AMCP’s July press release and social media shoutouts at AMCPs 2025 Nexus

View Media Kit

Related